Tips for Supply Chain to Improve Physician Buy-In. Part 4 of 4.

Posted by David Zieve, MD, MHA, Medical Director on March 22, 2017

We’ve reached the final stretch of our physician engagement blog. Thanks for sticking with us! By now, we hope you’ve already applied some of our suggestions as to how to improve your physician buy-in. Don’t forget to share this blog with your supply chain and value analysis peers as well as the physicians in your hospital or health system. While you’re here, download our companion eBook for a lighthearted look at the challenges of physician engagement. Who couldn’t use a good laugh?

Let’s wrap up part 4 with our final piece of advice!

Read More

Topics: Hospitals, Hayes Blog, Health Technology Assessments,

Does Evidence Have a Role in Treating the Opioid Epidemic?

America has an opioid problem.

According to a 2016 report from the American Society of Addiction Medicine (ASAM), drug overdose is the leading cause of accidental death in the U.S., with 52,404 lethal drug overdoses in 2015. Of that number, 20,101 overdose deaths were related to prescription opioid pain relievers and 12,990 overdose deaths were related to heroin in 2015. In 2012, 259 million prescriptions were written for opioids; 80% of new heroin users began by misusing prescription painkillers. 

Read More

Topics: Health Technologies, Payers, Hospitals, Hayes Blog

New Methodology Webinar Focuses on Supply Chain and Value Analysis

Despite the possibility of impending changes to current healthcare regulations, it appears, at least for the moment, that value-based purchasing and bundled payment plans are here to stay. As a result, hospitals and health systems must scrutinize their decision-making processes around health technology acquisitions, product standardization, and utilization management. As part of that process, it is incumbent upon both supply chain/value analysis professionals and clinicians to consider three important questions:

Read More

Topics: Hospitals, Hayes Blog, Health Technology Assessments,

Big Data, MACRA, and Evidence: What’s the link?

By now, it’s probably safe to say that some, if not all, of you have experienced some level of “big data fatigue.” The phrase has become ubiquitous, no matter the industry, although it seems none more so than in healthcare. Indeed, almost every healthcare news source to which I subscribe these days seems to have weekly articles, essays, white papers and blogs about big data. But there’s a common thread often missing from these reports. While they all report on the inevitability of big data’s influence on the healthcare sphere, as well as the manner in which electronic health/medical records (EHR/EMR) will continue to impact the future of care delivery, there is little discussion of the role of evidence as it relates to big data.

Read More

Topics: Hospitals, Hayes Blog, Healthcare Evidence, Medicare

Tips for Supply Chain to Improve Physician Buy-In: Part 3 of 4

Posted by David Zieve, MD, MHA, Medical Director on March 7, 2017

Back for more? Great! We hope these tips are proving helpful in improving your physician buy-in. If so, please share this blog with your supply chain and value analysis peers who might also be experiencing your struggles. If you haven’t already, download the companion eBook for a lighthearted look at the challenges of physician engagement.

On to part 3!

Read More

Topics: Hospitals, Hayes Blog, Healthcare Evidence

Tips for Supply Chain to Improve Physician Buy-In: Part 2 of 4

Posted by David Zieve, MD, MHA, Medical Director on February 23, 2017

Welcome back!

We hope you found the first two tips for physician engagement helpful in sparking some ideas as well in initiating conversation with some of your clinical committees. If you missed it, check out part one of this blog series here.

Let’s pick up where we left off last time. Without further ado…

 

 

Read More

Topics: Hospitals, Hayes Blog, Healthcare Evidence

Get Engaged: Tips for Supply Chain to Improve Physician Buy-In: Part 1 of 4

Posted by David Zieve, MD, MHA, Medical Director on February 14, 2017

Valentine’s Day is upon us once again. What better time to talk about engagements? While we don’t mean the kind that will send you walking down the aisle, we are talking about developing solid relationships with your physicians. In this evolving value-based purchasing (VBP) and evidence-based medicine (EBM) environment, getting buy-in from physicians on your technology acquisition, product standardization, and utilization management initiatives is crucial. Today we will provide you with some tips as part of a new series about how you as supply chain and value analysis professionals can use evidence to foster and/or improve your physician buy-in. These insider suggestions won’t require you to go on bended knee to effectively engage with your physicians and clinical leadership.

Read More

Topics: Hospitals, Hayes Blog, Healthcare Evidence

Analytical Validity, Clinical Validity, and Clinical Utility: What’s the Difference?

Posted by The Evidence Blog on February 7, 2017

Genetic testing is seemingly everywhere today. No longer are discussions of tumor profiling, gene panels, genomics and proteomics confined to the scientific realm. Major news outlets cover new advances in genetic testing, as well as some of the hidden risks associated with their exponential growth in the consumer market (See our blog Evidence Shines a Light on the Hidden Dangers of Genetic Testing). Technical innovations, such as next-generation sequencing, have accelerated the development of such tests. Consequently, there is increasing demand on you as both physicians and payers to provide your patients and clients with the best possible test solutions. But how do you decide? There are three essential criteria to consider when making your determinations regarding genetic testing.

Read More

Topics: Payers, Hospitals, Hayes Blog, Healthcare Evidence, Genetic Testing

Evidence-Based Medicine and the Necessity of Science

Posted by Winifred S. Hayes, RN, PhD, ANP, Founder and CEO on February 1, 2017

There’s no disputing that the current state of healthcare is in flux. Regardless of public opinion and political leanings about the topic, the manner in which clinicians and health systems deliver care is changing, and more disruption to long-accepted paradigms is on the horizon. Though the move away from fee-for-service medicine has been in existence for some time, the adoption of an evidence-based approach in the provider market has been uneven at best. Perhaps now more than ever, a refocusing is required on just what evidence-based medicine (EBM) is, and why the application of the scientific method to healthcare delivery is essential to achieving the crucial Triple Aim.

Read More

Topics: Hospitals, Hayes Blog, Healthcare Evidence, Health Technology Assessments,, Medicare

JAMA: Sepsis Responsible for Highest Rate of Hospital Readmissions

Last week, the Journal of the American Medical Association (JAMA) released a report about research performed at the University Of Pittsburgh School Of Medicine and the VA Pittsburgh Healthcare System. The findings revealed that sepsis, a potentially fatal condition triggered by an infection in the bloodstream, has a greater readmission rate (12.2%) than all four of the medical conditions currently tracked by the Centers for Medicare & Medicaid Services (CMS). Those conditions are:

Read More

Topics: Hospitals, Hayes Blog, Healthcare Evidence, Medicare

Sign up to receive updates from our blog

Our latest articles

New Call-to-action